New guidelines for prevention and management of implantable cardiac electronic device-related infection

About 40 000 ICEDs were implanted in the UK in 2010, and the number of implantations of implantable cardiac defibrillators and cardiac resynchronisation therapy devices is increasing by 12-15% every year. 3 Although robust data for rates of ICED infection within the UK National Health Service (NHS)...

Full description

Saved in:
Bibliographic Details
Published in:The Lancet (British edition) 2015-06, Vol.385 (9984), p.2225-2226
Main Authors: Sandoe, Jonathan A T, Barlow, Gavin, Chambers, John B, Gammage, Michael, Guleri, Achyut, Howard, Philip, Olson, Ewan, Perry, John D, Prendergast, Bernard D, Spry, Michael J, Steeds, Richard P, Tayebjee, Muzahir H, Watkin, Richard
Format: Article
Language:English
Subjects:
Cardiac Resynchronization Therapy Devices - adverse effects
Cardiology
Defibrillators, Implantable - adverse effects
Device Removal - standards
Humans
Infections
Internal Medicine
Medical equipment
Operating Rooms - standards
Practice Guidelines as Topic
Prosthesis-Related Infections - microbiology
Prosthesis-Related Infections - prevention & control
Prosthesis-Related Infections - therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:About 40 000 ICEDs were implanted in the UK in 2010, and the number of implantations of implantable cardiac defibrillators and cardiac resynchronisation therapy devices is increasing by 12-15% every year. 3 Although robust data for rates of ICED infection within the UK National Health Service (NHS) are not available, anecdotal evidence suggests that such infections are increasingly common.
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(14)62249-2